Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune responses to myxoma virus.

Peter Kerr1, Grant McFadden

  • 1Pest Animal Control Cooperative Research Centre, CSIRO Sustainable Ecosystems, Canberra, ACT, Australia. Peter.Kerr@csiro.au

Viral Immunology
|June 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Divergence in poxvirus-encoded E3-like proteins can dictate poxvirus activation of cellular necroptosis.

Journal of virology·2026
Same author

Poxvirus attack of antiviral defense pathways unleashes an effector-triggered NF-κB response.

Science (New York, N.Y.)·2026
Same author

Virus-derived serpin reduces immuno-coagulopathic damage in murine colitis by targeting the urokinase-type plasminogen activator receptor (uPAR) and complement.

Scientific reports·2025
Same author

Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication.

Viruses·2025
Same author

Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood-Brain Barrier and Treat Murine Glioma.

International journal of molecular sciences·2024
Same author

Pharmaceutical Pollution of the English National Parks.

Environmental toxicology and chemistry·2024
Same journal

Reovirus Reassortants Reveal Context-Dependent Oncolytic Phenotypes Across Epithelial Cancer Cell Lines.

Viral immunology·2026
Same journal

Syncytia Formation in the Pathogenesis of SARS-CoV-2 Infection: Lessons from Viral Infections.

Viral immunology·2026
Same journal

Screening and Characterization of Nanobody Against the Emerging Dairy Cattle H5N1 Influenza Virus.

Viral immunology·2026
Same journal

Immunoinformatics-Driven Design of a Multiepitope Vaccine for Rustrela Virus-Induced Neurological Diseases: A New Frontier in Encephalitis and Meningoencephalitis Prevention.

Viral immunology·2026
Same journal

Single-Cell Transcriptomic Profiling Reveals Molecular Alterations in the Airway Epithelial Cells of Children with Wheezing Infected by Respiratory Syncytial Virus.

Viral immunology·2026
Same journal

Effect of Pentoxifylline on Inflammatory Markers in COVID-19: A Meta-Analysis of Randomized Controlled Trials.

Viral immunology·2026
See all related articles

Myxoma virus, a poxvirus, causes disease in European rabbits by suppressing their immune systems. Understanding its molecular interactions is key to studying rabbit resistance and the virus

Area of Science:

  • Virology and Immunology
  • Infectious Disease Dynamics
  • Evolutionary Biology

Background:

  • Myxoma virus (MYXV) causes severe myxomatosis in European rabbits (Oryctolagus cuniculus), a species it jumped to from South American rabbits.
  • MYXV, a poxvirus, possesses genes encoding proteins that modulate host immune responses, including innate and acquired immunity.
  • Viral proteins inhibit apoptosis and facilitate replication in host immune cells like lymphocytes and monocytes.

Purpose of the Study:

  • To review detailed molecular studies of myxoma virus.
  • To discuss the pathogenesis of myxomatosis in rabbits.
  • To explore the evolution of genetic resistance in wild rabbits and the species barrier.

Main Methods:

  • Review of existing literature on myxoma virus molecular biology.

Related Experiment Videos

  • Analysis of viral proteins involved in immune evasion.
  • Discussion of host-pathogen interactions and immune responses.

    • Main Results:

    • Detailed molecular characterization of MYXV proteins reveals novel immune evasion strategies.
    • Understanding viral replication mechanisms in host immune cells provides insights into pathogenesis.
    • Limited knowledge exists on the dynamics of host-immune system interaction during infection and resistance evolution.

    Conclusions:

    • Molecular studies illuminate MYXV's interaction with the host immune system.
    • Further research is needed on the integrated host-immune response dynamics and genetic resistance to myxomatosis.
    • Investigating the species barrier and coevolution provides a model for large DNA virus-host interactions.